Valeant shares drop as CEO returns, it cancels fourth-quarter report
 

Valeant shares drop as CEO returns, it cancels fourth-quarter report
(Reuters) - Shares in embattled drugmaker Valeant Pharmaceuticals International Inc fell as much as 21 percent on Monday, a day after the company canceled the release of fourth-quarter earnings, withdrew 2016 financial guidance and said its chief executive had returned from medical leave.
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...fA:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...fA:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/3ubREZyeDxI